Tigermed Reports Fiscal 2025 Earnings with Net Profit Attributable to Shareholders Surging 119.15% to 888 Million Yuan

Stock News03-30

Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ) has released its annual report for the fiscal year 2025. The company achieved operating revenue of 6.833 billion yuan, representing a year-on-year increase of 3.48%. Net profit attributable to shareholders of the listed company was 888 million yuan, a significant surge of 119.15% compared to the previous year. However, net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 355 million yuan, marking a decrease of 58.47% year-on-year. Basic earnings per share stood at 1.04 yuan. Furthermore, the company proposed a dividend distribution of 1.26 yuan per 10 shares (before tax) to all shareholders.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1173928169?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-30 19:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1173928169","market":"sg","top_or_hot":-1,"title":"Tigermed Reports Fiscal 2025 Earnings with Net Profit Attributable to Shareholders Surging 119.15% to 888 Million Yuan","media":"Stock News","content":"<p>Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ) has released its annual report for the fiscal year 2025. The company achieved operating revenue of 6.833 billion yuan, representing a year-on-year increase of 3.48%. Net profit attributable to shareholders of the listed company was 888 million yuan, a significant surge of 119.15% compared to the previous year. However, net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 355 million yuan, marking a decrease of 58.47% year-on-year. Basic earnings per share stood at 1.04 yuan. Furthermore, the company proposed a dividend distribution of 1.26 yuan per 10 shares (before tax) to all shareholders.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tigermed Reports Fiscal 2025 Earnings with Net Profit Attributable to Shareholders Surging 119.15% to 888 Million Yuan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTigermed Reports Fiscal 2025 Earnings with Net Profit Attributable to Shareholders Surging 119.15% to 888 Million Yuan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-03-30 19:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ) has released its annual report for the fiscal year 2025. The company achieved operating revenue of 6.833 billion yuan, representing a year-on-year increase of 3.48%. Net profit attributable to shareholders of the listed company was 888 million yuan, a significant surge of 119.15% compared to the previous year. However, net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 355 million yuan, marking a decrease of 58.47% year-on-year. Basic earnings per share stood at 1.04 yuan. Furthermore, the company proposed a dividend distribution of 1.26 yuan per 10 shares (before tax) to all shareholders.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0174","symbol_name":"增持","start_time":0,"source_url":"","article_id":"1173928169","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1173928169","pubTimestamp":1774869161,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ) has released its annual report for the fiscal year 2025. The company achieved operating revenue of 6.833 billion yuan, representing a year-on-year...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300347":"泰格医药","BK0174":"增持","BK0077":"质押式回购","BK0216":"研究试验","03347":"泰格医药","BK0028":"国家队","BK1141":"生命科学工具和服务","LU1146622755.USD":"安本中国A股股票基金A Acc","BK1583":"高瓴概念","BK1576":"医药外包概念","LU1820825898.SGD":"Aberdeen Standard SICAV I - China A Share Equity A Acc SGD-H"},"translate_title":"泰格医药公布2025财年盈利归属股东净利润飙升119.15%至8.88亿元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300347":1,"03347":1},"content_text":"Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ) has released its annual report for the fiscal year 2025. The company achieved operating revenue of 6.833 billion yuan, representing a year-on-year increase of 3.48%. Net profit attributable to shareholders of the listed company was 888 million yuan, a significant surge of 119.15% compared to the previous year. However, net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 355 million yuan, marking a decrease of 58.47% year-on-year. Basic earnings per share stood at 1.04 yuan. Furthermore, the company proposed a dividend distribution of 1.26 yuan per 10 shares (before tax) to all shareholders.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.41.0","shortVersion":"4.41.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1173928169","isCrawlerRequest":true}